| review article | Q7318358 |
| scholarly article | Q13442814 |
| P2093 | author name string | Gary Goldenberg | |
| Julien Lanoue | |||
| P2860 | cites work | Nevoid basal cell carcinoma syndrome (Gorlin syndrome) | Q21202903 |
| Epidemiology and Economic Burden of Nonmelanoma Skin Cancer | Q22252210 | ||
| Interventions for basal cell carcinoma of the skin | Q24246327 | ||
| Molecular mechanisms of tazarotene action in psoriasis | Q28116045 | ||
| Imiquimod: modes of action | Q28184438 | ||
| Solasodine glycoalkaloids: a novel topical therapy for basal cell carcinoma. A double-blind, randomized, placebo-controlled, parallel group, multicenter study | Q28263477 | ||
| Identification of mutations in the human PATCHED gene in sporadic basal cell carcinomas and in patients with the basal cell nevus syndrome | Q28273158 | ||
| Photodynamic therapy of primary nonmelanomatous skin tumours of the head and neck | Q30743473 | ||
| Basal cell carcinoma, squamous cell carcinoma and melanoma of the skin: analysis of the Singapore Cancer Registry data 1968-97. | Q30807303 | ||
| Can the carbon dioxide laser completely ablate basal cell carcinomas? A histological study. | Q30883362 | ||
| Superpulsed CO2 laser treatment of basal cell carcinoma with intraoperatory histopathologic and cytologic examination | Q33185048 | ||
| Metastatic basal cell carcinoma: rapid symptomatic response to cisplatin and paclitaxel | Q33206043 | ||
| Combination of Er:YAG laser and photodynamic therapy in the treatment of nodular basal cell carcinoma | Q33321614 | ||
| The efficacy of facial skin cancer treatment with high-energy pulsed neodymium and Nd:YAG lasers | Q33433140 | ||
| Long-term safety and efficacy of vismodegib in patients with advanced basal cell carcinoma: final update of the pivotal ERIVANCE BCC study | Q33691572 | ||
| Sustained Hedgehog signaling is required for basal cell carcinoma proliferation and survival: conditional skin tumorigenesis recapitulates the hair growth cycle | Q33763727 | ||
| Pulsed dye laser as a novel non-surgical treatment for basal cell carcinomas: response and follow up 12-21 months after treatment | Q33839658 | ||
| Treatment of skin carcinomas of the face by high-dose-rate brachytherapy and custom-made surface molds | Q33843827 | ||
| Lasers in the treatment of nonmelanoma skin cancer. | Q33849381 | ||
| Metastatic basal cell carcinoma: complete response to chemotherapy and associated pure red cell aplasia | Q42496871 | ||
| Similar effectiveness of methyl aminolevulinate and 5-aminolevulinate in topical photodynamic therapy for nodular basal cell carcinoma. | Q42498706 | ||
| Imiquimod 5% cream as pretreatment of Mohs micrographic surgery for nodular basal cell carcinoma in the face: a prospective randomized controlled study | Q42502892 | ||
| Photodynamic therapy with meta-tetrahydroxyphenylchlorin for basal cell carcinoma: a phase I/II study | Q42507279 | ||
| Quality-of-life outcomes of treatments for cutaneous basal cell carcinoma and squamous cell carcinoma | Q42508358 | ||
| Fifty-five basal cell carcinomas treated with topical imiquimod: outcome at 5-year follow-up | Q42508531 | ||
| Trends in non-melanocytic skin cancer treated in Australia: the second national survey | Q42510047 | ||
| Selective distribution of porphyrins in skin thick basal cell carcinoma after topical application of methyl 5-aminolevulinate | Q42510415 | ||
| 5% 5-Fluorouracil cream for the treatment of small superficial Basal cell carcinoma: efficacy, tolerability, cosmetic outcome, and patient satisfaction | Q42510984 | ||
| Light fractionation significantly improves the response of superficial basal cell carcinoma to aminolaevulinic acid photodynamic therapy: five-year follow-up of a randomized, prospective trial | Q42512459 | ||
| A phase III, randomized, open label study to evaluate the safety and efficacy of imiquimod 5% cream applied thrice weekly for 8 and 12 weeks in the treatment of low-risk nodular basal cell carcinoma. | Q42515208 | ||
| Cost of nonmelanoma skin cancer treatment in the United States | Q42517481 | ||
| Five-year follow-up of a randomized, prospective trial of topical methyl aminolevulinate photodynamic therapy vs surgery for nodular basal cell carcinoma | Q42518937 | ||
| Treatment of basal-cell carcinoma: comparison of radiotherapy and cryotherapy | Q42521388 | ||
| Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: a double-blind, randomized, vehicle-controlled study | Q42525212 | ||
| Efficacy of topical 5% imiquimod cream for the treatment of nodular basal cell carcinoma: comparison of dosing regimens | Q42525863 | ||
| Nonsurgical treatment of basal cell carcinomas with intralesional 5-fluorouracil/epinephrine injectable gel. | Q42528781 | ||
| Incidence estimate of nonmelanoma skin cancer in the United States, 2006. | Q45385584 | ||
| PDT as a cytotoxic agent and biological response modifier: Implications for cancer prevention and treatment in immunosuppressed and immunocompetent patients | Q46947476 | ||
| [Epidemiology of epithelial skin cancers] | Q57697108 | ||
| Photodynamic therapy for the treatment of basal cell carcinoma | Q67597474 | ||
| Cesium-137 brachytherapy for epithelioma of the skin of the nose: experience with 370 patients | Q72000885 | ||
| Nonmelanoma skin cancer | Q82682059 | ||
| Basal cell carcinoma | Q84478510 | ||
| Nonmelanoma skin cancer treated with electronic brachytherapy: results at 1 year | Q85891701 | ||
| Efficacy and safety of vismodegib in advanced basal-cell carcinoma. | Q34032213 | ||
| Ingenol mebutate gel for actinic keratosis | Q34261250 | ||
| Tazarotene induces apoptosis in human basal cell carcinoma via activation of caspase-8/t-Bid and the reactive oxygen species-dependent mitochondrial pathway | Q34266288 | ||
| Recurrence rates of treated basal cell carcinomas. Part 3: Surgical excision | Q34423090 | ||
| Radiotherapy for epithelial skin cancer | Q34430151 | ||
| Guidelines for topical photodynamic therapy: report of a workshop of the British Photodermatology Group. | Q34609484 | ||
| Open-label, exploratory phase II trial of oral itraconazole for the treatment of basal cell carcinoma | Q35086789 | ||
| Inhibiting the hedgehog pathway in patients with the basal-cell nevus syndrome | Q35184597 | ||
| The role of the 595-nm pulsed dye laser in treating superficial basal cell carcinoma: outcome of a double-blind randomized placebo-controlled trial | Q35209427 | ||
| Topical methyl aminolaevulinate photodynamic therapy in patients with basal cell carcinoma prone to complications and poor cosmetic outcome with conventional treatment. | Q35607555 | ||
| Basal cell carcinomas: attack of the hedgehog | Q35687900 | ||
| delta-Aminolevulinic acid and blue light photodynamic therapy for treatment of multiple basal cell carcinomas in two patients with nevoid basal cell carcinoma syndrome | Q35812851 | ||
| Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years | Q36224045 | ||
| Single and multiple dose intravenous and oral pharmacokinetics of the hedgehog pathway inhibitor vismodegib in healthy female subjects | Q36390239 | ||
| Clinical variants, stages, and management of basal cell carcinoma | Q36612692 | ||
| Tumor recurrence 5 years after treatment of cutaneous basal cell carcinoma and squamous cell carcinoma | Q37012850 | ||
| Initial assessment of tumor regrowth after vismodegib in advanced Basal cell carcinoma | Q37183367 | ||
| Metastatic basal cell carcinoma: report of twelve cases with a review of the literature | Q37241968 | ||
| Topical imiquimod or fluorouracil therapy for basal and squamous cell carcinoma: a systematic review | Q37660824 | ||
| The use of brachytherapy in the treatment of nonmelanoma skin cancer: a review | Q37865757 | ||
| Overall treatment success after treatment of primary superficial basal cell carcinoma: a systematic review and meta-analysis of randomized and nonrandomized trials | Q38011775 | ||
| Systemic treatments for basal cell carcinoma (BCC): the advent of dermato-oncology in BCC. | Q38089086 | ||
| Nontraditional management of basal cell carcinoma | Q38105009 | ||
| Nonmelanoma skin cancer in young women | Q38105012 | ||
| Basal cell carcinoma: a paradigm for targeted therapies | Q38105172 | ||
| Medical approaches to non-melanoma skin cancer | Q38162923 | ||
| Nonsurgical treatment options for basal cell carcinoma - focus on advanced disease | Q38168457 | ||
| Emerging drugs and combination strategies for basal cell carcinoma | Q38207707 | ||
| Topical pharmacotherapy for skin cancer: part I. Pharmacology | Q38211970 | ||
| Quality of life in non-melanoma skin cancer. | Q38246677 | ||
| Imiquimod directly inhibits Hedgehog signalling by stimulating adenosine receptor/protein kinase A-mediated GLI phosphorylation. | Q39101564 | ||
| Basal cell skin carcinoma and other nonmelanoma skin cancers in Finland from 1956 through 1995. | Q39513061 | ||
| Platinum-based cytotoxic therapy in basal cell carcinoma--a review of the literature | Q41236075 | ||
| Treatment of basal cell carcinoma of the skin with 5-fluorouracil ointment. A 10-year follow-up study | Q41557375 | ||
| Basal cell carcinoma of the face: surgery or radiotherapy? Results of a randomized study | Q41830527 | ||
| Advanced Basal Cell Carcinoma: Epidemiology and Therapeutic Innovations | Q42433643 | ||
| Fluorouracil paste treatment of thin basal cell carcinomas | Q42435079 | ||
| Cisplatin and doxorubicin. An effective chemotherapy combination in the treatment of advanced basal cell and squamous carcinoma of the skin | Q42436449 | ||
| Fractionated 5-aminolevulinic acid photodynamic therapy after partial debulking versus surgical excision for nodular basal cell carcinoma: a randomized controlled trial with at least 5-year follow-up | Q42436870 | ||
| Update on metastatic basal cell carcinoma: a summary of published cases from 1981 through 2011. | Q42438522 | ||
| Photodynamic therapy versus topical imiquimod versus topical fluorouracil for treatment of superficial basal-cell carcinoma: a single blind, non-inferiority, randomised controlled trial | Q42438662 | ||
| Topical methyl aminolaevulinate photodynamic therapy versus cryotherapy for superficial basal cell carcinoma: a 5 year randomized trial | Q42440062 | ||
| Fractionated 5-aminolaevulinic acid-photodynamic therapy vs. surgical excision in the treatment of nodular basal cell carcinoma: results of a randomized controlled trial | Q42440582 | ||
| Tendency of fluorouracil to conceal deep foci of invasive basal cell carcinoma | Q42442263 | ||
| Effects of 5-Fluorouracil (5-FU) Ointment on Normal and Diseased Skin Histological Findings and Deep Action | Q42442849 | ||
| Recurrence rate of superficial basal cell carcinoma following treatment with imiquimod 5% cream: conclusion of a 5-year long-term follow-up study in Europe | Q42443881 | ||
| Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib | Q42447885 | ||
| Surgical excision versus imiquimod 5% cream for nodular and superficial basal-cell carcinoma (SINS): a multicentre, non-inferiority, randomised controlled trial | Q42450869 | ||
| Mechanisms underlying imiquimod-induced regression of basal cell carcinoma in vivo | Q42451605 | ||
| Epidemiology and aetiology of basal cell carcinoma | Q42452718 | ||
| Photodynamic therapy of multiple nonmelanoma skin cancers with verteporfin and red light-emitting diodes: two-year results evaluating tumor response and cosmetic outcomes | Q42455811 | ||
| The effect of intralesional 5-fluorouracil therapeutic implant (MPI 5003) for treatment of basal cell carcinoma | Q42456541 | ||
| Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies | Q42460540 | ||
| An investigator-initiated open-label clinical trial of vismodegib as a neoadjuvant to surgery for high-risk basal cell carcinoma | Q42460656 | ||
| Responsiveness of metastatic basal-cell carcinoma to chemotherapy. A case report | Q42461065 | ||
| Chemotherapy for metastatic basal cell carcinoma | Q42464805 | ||
| Topical treatment of basal cell carcinoma with tazarotene: a clinicopathological study on a large series of cases | Q42465127 | ||
| Preoperative treatment of advanced skin carcinoma with cisplatin and bleomycin | Q42468120 | ||
| Clinical, histological and demographic predictors for recurrence and second primary tumours of head and neck basal cell carcinoma. A 1062 patient-cohort study from a tertiary cancer referral hospital | Q42470498 | ||
| PEP005 (ingenol mebutate) gel for the topical treatment of superficial basal cell carcinoma: results of a randomized phase IIa trial. | Q42472861 | ||
| Sustained clearance of superficial basal cell carcinomas treated with imiquimod cream 5%: results of a prospective 5-year study | Q42475065 | ||
| Efficacy and tolerability of imiquimod 5% cream to treat periocular basal cell carcinomas. | Q42475565 | ||
| A phase II, multicenter, open-label, 3-cohort trial evaluating the efficacy and safety of vismodegib in operable basal cell carcinoma | Q42476191 | ||
| Life-threatening toxicity in a dihydropyrimidine dehydrogenase-deficient patient after treatment with topical 5-fluorouracil. | Q42477074 | ||
| Imiquimod treatment of superficial and nodular basal cell carcinoma: 12-week open-label trial. | Q42477168 | ||
| Long-term outcome after treatment with 5% topical imiquimod cream in patients with basal cell carcinoma of the eyelids | Q42477828 | ||
| Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from a randomized vehicle-controlled phase III study in Europe | Q42478119 | ||
| Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience | Q42478415 | ||
| Trends of nonmelanoma skin cancer from 1960 through 2000 in a Canadian population | Q42481226 | ||
| Preliminary observations on the use of topical tazarotene to treat basal-cell carcinoma. | Q42481522 | ||
| Complete response of metastatic basal cell carcinoma to cisplatin chemotherapy: a report on two patients | Q42482597 | ||
| Nonsurgical treatment options for Basal cell carcinoma | Q42483146 | ||
| Metastatic basal cell carcinoma: response to chemotherapy | Q42484464 | ||
| Topical treatment of Basal cell carcinomas in nevoid Basal cell carcinoma syndrome with a smoothened inhibitor | Q42485740 | ||
| A pilot study to evaluate the treatment of basal cell carcinoma with 5-fluorouracil using phosphatidyl choline as a transepidermal carrier | Q42486390 | ||
| Pilot study of imiquimod 5% cream as adjunctive therapy to curettage and electrodesiccation for nodular basal cell carcinoma | Q42488881 | ||
| Evaluation of cosmetic results of a randomized trial comparing surgery and radiotherapy in the treatment of basal cell carcinoma of the face | Q42488967 | ||
| An open-label, pilot study examining the efficacy of curettage followed by imiquimod 5% cream for the treatment of primary nodular basal cell carcinoma | Q42489119 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 26-36 | |
| P577 | publication date | 2016-05-01 | |
| P1433 | published in | The Journal of clinical and aesthetic dermatology | Q26842086 |
| P1476 | title | Basal Cell Carcinoma: A Comprehensive Review of Existing and Emerging Nonsurgical Therapies | |
| P478 | volume | 9 |
| Q57821304 | Basal Cell Carcinoma Arises from Interfollicular Layer of Epidermis |
| Q88962147 | Basal Cell Carcinoma: A Patient and Physician's Experience |
| Q90688856 | Clues to primary vismodegib resistance lie in histology and genetics |
| Q92978098 | Gene-Related Response of Basal Cell Carcinoma to Biologic Treatment with Vismodegib |
| Q93015773 | Giant Ulcerative Basal Cell Carcinoma with Local Metastasis: A Case Report and Assessment of Surgical Techniques |
| Q90396590 | Metformin as an Adjuvant to Photodynamic Therapy in Resistant Basal Cell Carcinoma Cells |
| Q38676352 | Neuroendocrine factors: The missing link in non‑melanoma skin cancer (Review). |
| Q58786646 | Photodynamic Therapy for Metastatic Melanoma Treatment: A Review |
| Q41179770 | Pigmented Paraaxillary Located "Complex" Basal Cell Carcinoma Imitating clinically irritated Melanocytic Lesion - Succesfull Surgical Approach in Bulgarian Patient |
| Q50531920 | Successful Craniotomy for Advanced Basal Cell Carcinomas with Cranial Bone Invasion and Dura Mater Infiltration - Unique Presentation in a Bulgarian Patient. |
Search more.